Willem D Rinkel1, Jacky Luiten2, Jelle van Dongen2, Bram Kuppens2, Johan W Van Neck3, Suzanne Polinder4, Manuel Castro Cabezas5, J Henk Coert6. 1. Department of Plastic-, Reconstructive- and Hand Surgery, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands; Department of Plastic-, Reconstructive- and Hand Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands. Electronic address: w.rinkel@franciscus.nl. 2. Department of Plastic-, Reconstructive- and Hand Surgery, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands; Department of Plastic-, Reconstructive- and Hand Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands. 3. Department of Plastic-, Reconstructive- and Hand Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands. 4. Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands. 5. Department of Internal Medicine/Centre for Diabetes, Endocrinology and Vascular Medicine, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands. 6. Department of Plastic-, Reconstructive- and Hand Surgery, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands; Department of Plastic-, Reconstructive- and Hand Surgery, Utrecht University Medical Center, Utrecht, The Netherlands.
Abstract
BACKGROUND: The diabetic foot imposes significant burden on healthcare systems. Obtaining knowledge on the extent of the costs of diabetic foot ulcers (DFUs) is of value to health care researchers investigating cost-effectiveness of interventions that prevent these costly complications. OBJECTIVES: To estimate the in-hospital costs associated with the treatment of DFUs by a multidisciplinary diabetic foot team. METHODS: Persons with DFUs presenting to our team in 2013 and 2014 were followed and use of care was estimated. Exclusion criteria were a single visit only and ulcers above the ankle. Demographic data and per-person incremental clinical outcomes (e.g., healing with or without amputation and rehabilitation) were assessed. Resource use was identified, measured and multiplied by unit costs. RESULTS: Eighty-nine persons were identified with 56 persons meeting the inclusion criteria (with 69 DFU episodes). The median in-hospital care was 17weeks (inter quartile range: 7-34). Average in-hospital costs were US$ 10,827 (range: 702-82,880) per DFU episode. Primary healed DFUs costs on average US$ 4830, single minor amputations on average US$ 13,580, multiple minor amputations on average US$ 31,835 and major amputations on average US$ 73,813 per episode. Costs differed significantly between groups (p<0.001). CONCLUSION: DFUs are associated with substantial immediate and long-term in-hospital costs. Our study provides estimates of these costs, aiding researchers and health policy analysis.
BACKGROUND: The diabetic foot imposes significant burden on healthcare systems. Obtaining knowledge on the extent of the costs of diabetic foot ulcers (DFUs) is of value to health care researchers investigating cost-effectiveness of interventions that prevent these costly complications. OBJECTIVES: To estimate the in-hospital costs associated with the treatment of DFUs by a multidisciplinary diabetic foot team. METHODS:Persons with DFUs presenting to our team in 2013 and 2014 were followed and use of care was estimated. Exclusion criteria were a single visit only and ulcers above the ankle. Demographic data and per-person incremental clinical outcomes (e.g., healing with or without amputation and rehabilitation) were assessed. Resource use was identified, measured and multiplied by unit costs. RESULTS: Eighty-nine persons were identified with 56 persons meeting the inclusion criteria (with 69 DFU episodes). The median in-hospital care was 17weeks (inter quartile range: 7-34). Average in-hospital costs were US$ 10,827 (range: 702-82,880) per DFU episode. Primary healed DFUs costs on average US$ 4830, single minor amputations on average US$ 13,580, multiple minor amputations on average US$ 31,835 and major amputations on average US$ 73,813 per episode. Costs differed significantly between groups (p<0.001). CONCLUSION: DFUs are associated with substantial immediate and long-term in-hospital costs. Our study provides estimates of these costs, aiding researchers and health policy analysis.
Authors: Ray Meng See; Yao Neng Teo; Yao Hao Teo; Nicholas L Syn; Alicia Swee Yan Yip; Shariel Leong; Caitlin Fern Wee; Alex Jia Yang Cheong; Chi-Hang Lee; Mark Yan-Yee Chan; Tiong Cheng Yeo; Raymond C C Wong; Peter Chang; Choon Chiet Hong; Ping Chai; Ching-Hui Sia Journal: Pharmacology Date: 2021-12-23 Impact factor: 2.547
Authors: Ché Matthew Harris; Aiham Albaeni; Roland J Thorpe; Keith C Norris; Marwan S Abougergi Journal: PLoS One Date: 2019-05-29 Impact factor: 3.240
Authors: Benjamin A R N Durand; Cassandra Pouget; Chloé Magnan; Virginie Molle; Jean-Philippe Lavigne; Catherine Dunyach-Remy Journal: Microorganisms Date: 2022-07-25